View of The impact of sarcopenia on the efficacy and safety of immune checkpoint inhibitors in patients with solid tumours

Return to Article Details The impact of sarcopenia on the efficacy and safety of immune checkpoint inhibitors in patients with solid tumours Download Download PDF